Shigeki Miyamoto

9PUBLICATIONS
34CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsMedical mycologyMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 30, 2026
NF-κB/RelA signaling required for CD40-induced humoral immunity depends on specific NEMO lysine residues in mice.

|Mar 11, 2025
NEMO is essential for directing the kinases IKKα and ATM to the sites of DNA damage.

Josune Alonso-Marañón, Laura Solé, Daniel Álvarez-Villanueva

|Aug 30, 2023
HAPLN1 matrikine: a bone marrow homing factor linked to poor outcomes in patients with MM.

Hae Yeun Chang, Mailee Huynh, Avtar Roopra

|Jan 10, 2023
Ectopic CH60 mediates HAPLN1-induced cell survival signaling in multiple myeloma.

Debayan De Bakshi, Yu-Chia Chen, Shelly M Wuerzberger-Davis

|Dec 08, 2022
HAPLN1 confers multiple myeloma cell resistance to several classes of therapeutic drugs.

Mailee Huynh, Hae Yeun Chang, Dominique N Lisiero

|Oct 25, 2022
The SUMO protease SENP1 promotes aggressive behaviors of high HIF2α expressing renal cell carcinoma cells.

Moon Hee Lee, Kyung Sung, David Beebe

Pageof 2

Frequent Collaborators

2 joint publications

Alexander Hoffmann

2 joint publications

Natalie S Callander

2 joint publications

Aussie Suzuki

2 joint publications

Yu-Chia Chen